DRAPER, Utah, Dec. 17, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce the publication of the third alternative medicine reference title authored by Company CEO, Dr. Tracy K. Gibbs, PhD.
"Your Guide to Oil of Oregano" (ISBN #978-0-9919788-0-9) by Dr. Tracy Gibbs, PhD., is a concise reference guide introducing the importance of phytochemicals and focusing on oregano and its many uses in herbal medicine and nutritional supplementation. Mannafest Publishing Inc. has printed over 70,000 copies of the book and to date over 50,000 copies are already in circulation. It is expected to be a "good seller" in the Health, Fitness, Diet, and Alternative Medicine categories. The book is expected to retail in stores and at Amazon.com for $9.95.
"I'm proud to have authored this book to introduce readers to the healing properties of oregano and the vital importance of phytochemicals in proper nutrition," stated Nutranomics CEO, Dr. Tracy K. Gibbs. "The book's substantial first run printing of over 70,000 copies should give a boost to the entire Nutranomics branded health food supplement line and open up additional potential distribution opportunities for the Company."
Dr. Gibbs has previously authored two other books published and distributed by Woodland Publishing; "My Home Pharmacy: How Foods and Herbs Can Be Your Medicine", and "Enzyme Power: Heal, Build, and Restore Health". Both titles can be found in a variety of book stores, health food stores, and at Amazon.com.
Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia.
For further information regarding Nutranomics, Inc., please contact our investor relations representatives at firstname.lastname@example.org or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include the Company's expectation that publication of this book will increase potential revenue and distribution opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
SOURCE Nutranomics, Inc.